MX2010008902A - Transportadores de nanoparticulas para administracion de farmacos y procedimiento para producir las mismas. - Google Patents

Transportadores de nanoparticulas para administracion de farmacos y procedimiento para producir las mismas.

Info

Publication number
MX2010008902A
MX2010008902A MX2010008902A MX2010008902A MX2010008902A MX 2010008902 A MX2010008902 A MX 2010008902A MX 2010008902 A MX2010008902 A MX 2010008902A MX 2010008902 A MX2010008902 A MX 2010008902A MX 2010008902 A MX2010008902 A MX 2010008902A
Authority
MX
Mexico
Prior art keywords
drug administration
nanoparticles
producing same
nanoparticle carriers
emulsion
Prior art date
Application number
MX2010008902A
Other languages
English (en)
Inventor
Lonji Kalombo
Original Assignee
Csir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csir filed Critical Csir
Publication of MX2010008902A publication Critical patent/MX2010008902A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a un procedimiento para la producción de transportadores de nanopartículas para administrar fármacos, en el que dichas nanopartículas se producen mediante: la preparación de una emulsión doble de agua-aceite-agua, que incluye uno o más polímeros que forma la base del transportador de nanopartículas; mezclar el fármaco que se va a administrar en una o más de las fases de emulsión; dopar la fase de aceite o la fase de agua externa con un hidrato de carbono; y secar mediante pulverización la emulsión para formar nanopartículas de una pequeña distribución de tamaños de partículas de 100 nm a 1000 nm, en la que las nanopartículas son sustancialmente esféricas.
MX2010008902A 2008-02-18 2008-02-18 Transportadores de nanoparticulas para administracion de farmacos y procedimiento para producir las mismas. MX2010008902A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ZA2008/000012 WO2009105792A1 (en) 2008-02-18 2008-02-18 Nanoparticle carriers for drug administration and process for producing same

Publications (1)

Publication Number Publication Date
MX2010008902A true MX2010008902A (es) 2011-03-02

Family

ID=39790304

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008902A MX2010008902A (es) 2008-02-18 2008-02-18 Transportadores de nanoparticulas para administracion de farmacos y procedimiento para producir las mismas.

Country Status (15)

Country Link
US (1) US8518450B2 (es)
EP (1) EP2249817B8 (es)
JP (1) JP5575667B2 (es)
CN (1) CN101951895B (es)
AP (1) AP2966A (es)
AT (1) ATE537817T1 (es)
AU (1) AU2008351331B2 (es)
CA (1) CA2714429C (es)
DE (1) DE112008003727T5 (es)
ES (1) ES2397016B1 (es)
GB (1) GB2469965B (es)
HK (1) HK1145973A1 (es)
MX (1) MX2010008902A (es)
WO (1) WO2009105792A1 (es)
ZA (1) ZA201006639B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8815294B2 (en) * 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
TWI462753B (zh) * 2011-11-29 2014-12-01 Univ Nat Chiao Tung 雙乳化核殼奈米結構及其製備方法
WO2013117671A1 (fr) * 2012-02-07 2013-08-15 Centre National De La Recherche Scientifique (C.N.R.S) Préparation de nanoparticules par évaporation flash
US9283298B2 (en) 2013-09-25 2016-03-15 Clemson University Compliant surgical adhesive
US9850521B2 (en) * 2014-08-01 2017-12-26 Agilent Technologies, Inc. In vitro assay buffer for Cas9
MA44833A (fr) * 2015-08-17 2018-06-27 Phosphorex Inc Nanoparticules extrêmement petites de polymères dégradables
TWI663991B (zh) * 2016-03-23 2019-07-01 中央研究院 薄殼聚合物奈米粒子及其用途
EP3836900A1 (en) * 2018-08-17 2021-06-23 Smela, Krzysztof Pawel Multicompartment system of nanocapsule-in-nanocapsule type, for encapsulation of a lipophilic and hydrophilic compound, and the related production method
CN109628547B (zh) * 2018-12-14 2022-02-25 陕西师范大学 一种改性磁珠、制备方法及其应用
EP3941439A1 (en) * 2019-05-14 2022-01-26 Council for Scientific and Industrial Research Polymer-lipid nanocomplex for enhanced aqueous solubilisation and absorption of hydrophobic active compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US20040018236A1 (en) * 1995-05-08 2004-01-29 Robert Gurny Nanoparticles for oral administration of pharmaceutical agents of low solubility
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
US7354886B2 (en) * 1999-07-29 2008-04-08 Baker Hughes Incorporated Pumpable multiple phase compositions for controlled release applications downhole
CN1406140A (zh) * 2000-02-28 2003-03-26 吉倪塞思公司 纳米胶囊包封系统与方法
WO2002034871A2 (en) * 2000-10-27 2002-05-02 Genencor International, Inc. Particle with substituted polyvinyl alcohol coating
JP2003175092A (ja) * 2001-07-10 2003-06-24 Canon Inc ポリヒドロキシアルカノエートを含有する粒状体及びその製造方法ならびにその用途
KR100521526B1 (ko) * 2001-07-10 2005-10-13 캐논 가부시끼가이샤 폴리하이드록시알카노에이트로 이루어진 입상 구조체 및그 제조방법
SI21222A (sl) * 2002-05-28 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo nanodelcev
ITTO20020452A1 (it) * 2002-05-29 2003-12-01 Vhit Spa Valvola pneumatica di limitazione del livello di depressione e sistema di frenatura comportante tale valvola.
CA2516339A1 (en) * 2003-02-19 2004-09-02 Takeda Pharmaceutical Company Limited Dispersing agent for sustained-release preparation
EP2063874B1 (en) * 2006-08-31 2013-04-03 SK Chemicals, Co., Ltd. Method for producing microspheres loaded with drugs and microspheres loaded with drugs produced thereby
US20100215580A1 (en) * 2006-09-08 2010-08-26 The Johns Hopkins University Compositions and methods for enhancing transport through mucus

Also Published As

Publication number Publication date
ATE537817T1 (de) 2012-01-15
GB2469965A (en) 2010-11-03
AU2008351331A1 (en) 2009-08-27
US8518450B2 (en) 2013-08-27
DE112008003727T5 (de) 2011-04-21
ZA201006639B (en) 2012-03-28
CN101951895B (zh) 2013-11-06
EP2249817B8 (en) 2012-03-21
CA2714429A1 (en) 2009-08-27
GB2469965B (en) 2012-06-20
AP2010005389A0 (en) 2010-10-31
GB2469965A8 (en) 2010-11-24
HK1145973A1 (en) 2011-05-13
ES2397016A1 (es) 2013-03-04
EP2249817A1 (en) 2010-11-17
CA2714429C (en) 2015-04-28
JP5575667B2 (ja) 2014-08-20
AP2966A (en) 2014-09-30
WO2009105792A1 (en) 2009-08-27
AU2008351331B2 (en) 2014-07-17
EP2249817B1 (en) 2011-12-21
US20110033550A1 (en) 2011-02-10
GB201013546D0 (en) 2010-09-29
JP2011512418A (ja) 2011-04-21
CN101951895A (zh) 2011-01-19
ES2397016B1 (es) 2014-01-17

Similar Documents

Publication Publication Date Title
GB2469965A (en) Nanoparticle carriers for drug administration and process for producing same
Nasrollahi et al. Targeted delivery of docetaxel by use of transferrin/poly (allylamine hydrochloride)-functionalized graphene oxide nanocarrier
Wang et al. Progress of electrospun nanofibrous carriers for modifications to drug release profiles
Díaz et al. Nanoparticles as drug delivery systems in cancer medicine: emphasis on RNAi-containing nanoliposomes
WO2010059963A3 (en) Preparation and methodology of silk fibroin nanoparticles
Chittasupho et al. Pectin nanoparticle enhances cytotoxicity of methotrexate against hepG2 cells
WO2012101639A3 (en) Nanoparticles based for dermal and systemic delivery of drugs
WO2013160773A3 (en) Polymeric nanoparticles and process of preparation thereof
WO2013093648A3 (en) Method of producing lipid nanoparticles for drug delivery
MX342439B (es) Metodos para producir nanoparticulas polimericas y formulaciones de ingredientes activos.
Uchegbu et al. Chitosan amphiphiles provide new drug delivery opportunities
GB201121288D0 (en) Functionalised silicon nanoparticles
Alserihi et al. Development of (−)-epigallocatechin-3-gallate-loaded folate receptor-targeted nanoparticles for prostate cancer treatment
MX2015010083A (es) Nanoparticulas biodegradables y clinicamente compatibles como portadores para administracion de farmacos.
MX2018014576A (es) Nanopartículas para el suministro de fármaco y tratamientos para el cáncer resistente a fármacos.
Guo et al. Synthesis and antitumoral activity of gelatin/polyoxometalate hybrid nanoparticles
Chen et al. Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy
Moghaddam et al. Fabrication of carboxymethyl chitosan nanoparticles to deliver paclitaxel for melanoma treatment
Bera et al. Biopolymer-Based Nanomaterials in Drug Delivery and Biomedical Applications
Carvalho et al. Docetaxel loaded in copaiba oil-nanostructured lipid carriers as a promising DDS for breast cancer treatment
Serini et al. Hyaluronic Acid-Mediated Phenolic Compound Nanodelivery for Cancer Therapy
Li et al. Fabrication of PLGA coated silica nanorattle for controlling the drug release behavior
Singh et al. Noscapine-Encapsulated Nanopolymers: A Novel Drug-Carrier System to Target the Tumor Cells
Liu et al. A tunable pH-responsive nanomaterials for cancer delivery
Ai et al. Tanima Bhattacharya

Legal Events

Date Code Title Description
FG Grant or registration